Tocilizumab treatment for new onset refractory status epilepticus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tocilizumab treatment for new onset refractory status epilepticus

Published:2018-11-30 Issue:6 Volume:84 Page:940-945
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Jun Jin-Sun¹,Lee Soon-Tae²^ORCID,Kim Ryul²,Chu Kon²^ORCID,Lee Sang Kun²

Affiliation:

1. Department of Neurology, School of Medicine; Kyungpook National University, Kyungpook National University Chilgok Hospital; Daegu South Korea

2. Department of Neurology; Seoul National University Hospital; Seoul South Korea

Funder

Ministry of Science, ICT, and Future Planning, Republic of Korea

Lee Sueng Moon Research Fund of Seoul National University Hospital

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ana.25374/fullpdf

Reference14 articles.

1. New-onset refractory status epilepticus: etiology, clinical features, and outcome;Gaspard;Neurology,2015

2. Refractory status epilepticus: frequency, risk factors, and impact on outcome;Mayer;Arch Neurol,2002

3. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): state of the art and perspectives;Gaspard;Epilepsia,2018

4. Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study;Lee;Neurotherapeutics,2016

5. Long-term therapy with interleukin 6 receptor blockade in highly active neuromyelitis optica spectrum disorder;Ringelstein;JAMA Neurol,2015

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis prediction and immunotherapy optimisation for cryptogenic new-onset refractory status epilepticus;Journal of Neurology, Neurosurgery & Psychiatry;2024-09-04

2. Successful Management of Febrile Infection–Related Epilepsy Syndrome Using Cytokine-Directed Therapy;Journal of Child Neurology;2024-08-28

3. Cytokines in new-onset refractory status epilepticus: ready for clinical use?;Acta Epileptologica;2024-07-01

4. Trends in management of patients with new‐onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis;Epilepsia;2024-06-05

5. Autoimmune‐associated seizure disorders;Epileptic Disorders;2024-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3